Literature DB >> 12937008

Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori.

Monique M Gerrits1, Marco Berning, Arnoud H M Van Vliet, Ernst J Kuipers, Johannes G Kusters.   

Abstract

The triple-base-pair 16S rDNA mutation AGA(926-928)-->TTC mediates high-level tetracycline resistance in Helicobacter pylori. In contrast, single- and double-base-pair mutations mediated only low-level tetracycline resistance and decreased growth rates in the presence of tetracycline, explaining the preference for the TTC mutation in tetracycline-resistant H. pylori isolates.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12937008      PMCID： PMC182601          DOI： 10.1128/AAC.47.9.2984-2986.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

Review 2.  Challenges to therapy in the future.

Authors:  C O'Morain; S Montague
Journal:  Helicobacter       Date:  2000       Impact factor: 5.753

3.  Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline.

Authors:  Catharine A Trieber; Diane E Taylor
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.

Authors:  G Realdi; M P Dore; A Piana; A Atzei; M Carta; L Cugia; A Manca; B M Are; G Massarelli; I Mura; A Maida; D Y Graham
Journal:  Helicobacter       Date:  1999-06       Impact factor: 5.753

Review 5.  How to treat Helicobacter pylori. First-line, second-line, and future therapies.

Authors:  F Mégraud; B J Marshall
Journal:  Gastroenterol Clin North Am       Date:  2000-12       Impact factor: 3.806

6.  Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.

Authors:  Ludmila Boyanova; Irina Stancheva; Zoya Spassova; Nikolai Katzarov; Ivan Mitov; Radka Koumanova
Journal:  J Med Microbiol       Date:  2000-05       Impact factor: 2.472

7.  Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.

Authors:  J J Kim; R Reddy; M Lee; J G Kim; F A El-Zaatari; M S Osato; D Y Graham; D H Kwon
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

8.  Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.

Authors:  D H Kwon; J J Kim; M Lee; Y Yamaoka; M Kato; M S Osato; F A El-Zaatari; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori.

Authors:  Monique M Gerrits; Marcel R de Zoete; Niek L A Arents; Ernst J Kuipers; Johannes G Kusters
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; A B Brinkman; E J Kuipers; C M Vandenbroucke-Grauls; J G Kusters
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191
View more
  23 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 2.  The tetracycline resistome.

Authors:  Maulik Thaker; Peter Spanogiannopoulos; Gerard D Wright
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

3.  Quinolone resistance in Helicobacter pylori isolates in Germany.

Authors:  Erik Glocker; Hans-Peter Stueger; Manfred Kist
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori.

Authors:  Erik Glocker; Marco Berning; Monique M Gerrits; Johannes G Kusters; Manfred Kist
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis.

Authors:  E Amram; I Mikula; C Schnee; R D Ayling; R A J Nicholas; R S Rosales; S Harrus; I Lysnyansky
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

7.  Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.

Authors:  Vincenzo De Francesco; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Rosa Rosania; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

8.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

9.  16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes.

Authors:  Lisa Nonaka; Sean R Connell; Diane E Taylor
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

10.  Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.

Authors:  Jeng Yih Wu; Jae J Kim; Rita Reddy; W M Wang; David Y Graham; Dong H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.